<- Go Home
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Market Cap
$1.7B
Volume
416.7K
Cash and Equivalents
$311.2M
EBITDA
$197.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$561.9M
Profit Margin
60.83%
52 Week High
$99.50
52 Week Low
$56.71
Dividend
N/A
Price / Book Value
3.07
Price / Earnings
20.72
Price / Tangible Book Value
52.87
Enterprise Value
$2.0B
Enterprise Value / EBITDA
10.04
Operating Income
$107.9M
Return on Equity
18.32%
Return on Assets
4.97
Cash and Short Term Investments
$326.1M
Debt
$630.2M
Equity
$562.3M
Revenue
$923.7M
Unlevered FCF
$160.0M
Sector
Pharmaceuticals
Category
N/A